{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T16:58:38Z","timestamp":1778173118699,"version":"3.51.4"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"36","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1097\/md.0000000000004526","type":"journal-article","created":{"date-parts":[[2016,9,7]],"date-time":"2016-09-07T12:53:32Z","timestamp":1473252812000},"page":"e4526","source":"Crossref","is-referenced-by-count":68,"title":["Effects of metformin on pregnancy outcomes in women with polycystic ovary syndrome"],"prefix":"10.1097","volume":"95","author":[{"given":"Xian-Ling","family":"Zeng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya-Fei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quan","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui-Fang","family":"An","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-12-20210226","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/0140-6736(90)92765-A","article-title":"Hypersecretion of luteinising hormone, infertility, and miscarriage","volume":"336","author":"Regan","year":"1990","journal-title":"Lancet (London, England"},{"key":"R2-12-20210226","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/oxfordjournals.humrep.a138149","article-title":"Hypersecretion of luteinizing hormone and ovarian steroids in women with recurrent early miscarriage","volume":"8","author":"Watson","year":"1993","journal-title":"Hum Reprod (Oxford, England"},{"key":"R3-12-20210226","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1111\/j.1447-0756.2008.00856.x","article-title":"Does continuous use of metformin throughout pregnancy improve pregnancy outcomes in women with polycystic ovarian syndrome?","volume":"34","author":"Nawaz","year":"2008","journal-title":"J Obstet Gynaecol Res"},{"key":"R4-12-20210226","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/humupd\/dml036","article-title":"A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome","volume":"12","author":"Boomsma","year":"2006","journal-title":"Hum Reprod Update"},{"key":"R5-12-20210226","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/0002-9378(92)91779-A","article-title":"Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome?","volume":"167","author":"Carmina","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"R6-12-20210226","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.2337\/diab.38.9.1165","article-title":"Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome","volume":"38","author":"Dunaif","year":"1989","journal-title":"Diabetes"},{"key":"R7-12-20210226","first-page":"139","article-title":"Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation","volume":"85","author":"Moghetti","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"R8-12-20210226","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.tjog.2013.06.020","article-title":"Effect of metformin on early pregnancy loss in women with polycystic ovary syndrome","volume":"54","author":"Al-Biate","year":"2015","journal-title":"Taiwanese J Obstet Gynecol"},{"key":"R9-12-20210226","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2165\/11534750-000000000-00000","article-title":"Clinical pharmacokinetics of metformin","volume":"50","author":"Graham","year":"2011","journal-title":"Clin Pharmacokinet"},{"key":"R10-12-20210226","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.4158\/EP14018.OR","article-title":"Metformin safety in the management of gestational diabetes","volume":"20","author":"Marques","year":"2014","journal-title":"Endocr Pract"},{"key":"R11-12-20210226","doi-asserted-by":"crossref","first-page":"E448","DOI":"10.1210\/jc.2010-0853","article-title":"Metformin versus placebo from first trimester to delivery in polycystic ovary syndrome: a randomized, controlled multicenter study","volume":"95","author":"Vanky","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"R12-12-20210226","first-page":"797","article-title":"The efficacy of metformin in pregnant women with polycystic ovary syndrome: a meta-analysis of clinical trials","volume":"36","author":"Zheng","year":"2013","journal-title":"J Endocrinol Invest"},{"key":"R13-12-20210226","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4236\/ojog.2013.31021","article-title":"Use of metformin during pregnancy for women with polycystic ovary syndrome","volume":"3","author":"H.F F","year":"2013","journal-title":"Open J Obstet Gynecol"},{"key":"R14-12-20210226","doi-asserted-by":"crossref","first-page":"381231","DOI":"10.1155\/2014\/381231","article-title":"Effect of metformin intervention during pregnancy on the gestational diabetes mellitus in women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"2014","author":"Zhuo","year":"2014","journal-title":"J Diabetes Res"},{"key":"R15-12-20210226","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/j.metabol.2013.06.006","article-title":"Efficacy and safety of metformin during pregnancy in women with gestational diabetes mellitus or polycystic ovary syndrome: a systematic review","volume":"62","author":"Lautatzis","year":"2013","journal-title":"Metabolism"},{"key":"R16-12-20210226","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"R17-12-20210226","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Control Clin Trials"},{"key":"R18-12-20210226","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"R19-12-20210226","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1093\/humrep\/deh347","article-title":"Metformin reduces pregnancy complications without affecting androgen levels in pregnant polycystic ovary syndrome women: results of a randomized study","volume":"19","author":"Vanky","year":"2004","journal-title":"Hum Reprod (Oxford, England"},{"key":"R20-12-20210226","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/uog.3965","article-title":"Metformin treatment in pregnant women with polycystic ovary syndrome\u2013is reduced complication rate mediated by changes in the uteroplacental circulation?","volume":"29","author":"Salvesen","year":"2007","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R21-12-20210226","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1080\/00365510802254620","article-title":"Metformin has no major effects on glucose homeostasis in pregnant women with PCOS: results of a randomized double-blind study","volume":"68","author":"Fougner","year":"2008","journal-title":"Scand J Clin Lab Invest"},{"key":"R22-12-20210226","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1210\/jc.2011-3061","article-title":"Metformin improves pregnancy and live-birth rates in women with polycystic ovary syndrome (PCOS): a multicenter, double-blind, placebo-controlled randomized trial","volume":"97","author":"Morin-Papunen","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"R23-12-20210226","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/j.1447-0756.2008.00876.x","article-title":"Prevention of gestational diabetes mellitus by continuing metformin therapy throughout pregnancy in women with polycystic ovary syndrome","volume":"35","author":"Begum","year":"2009","journal-title":"J Obstet Gynaecol Res"},{"key":"R24-12-20210226","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/S0015-0282(01)03202-2","article-title":"Metformin therapy throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome","volume":"77","author":"Glueck","year":"2002","journal-title":"Fert Steril"},{"key":"R25-12-20210226","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1080\/09513590601010508","article-title":"Metformin reduces abortion in pregnant women with polycystic ovary syndrome","volume":"22","author":"Khattab","year":"2006","journal-title":"Gynecol Endocrinol"},{"key":"R26-12-20210226","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1159\/000268051","article-title":"Continuation of metformin reduces early pregnancy loss in obese Pakistani women with polycystic ovarian syndrome","volume":"69","author":"Nawaz","year":"2010","journal-title":"Gynecol Obstet Invest"},{"key":"R27-12-20210226","doi-asserted-by":"crossref","first-page":"789","DOI":"10.3109\/09513590.2010.540600","article-title":"Can metformin reduce the incidence of gestational diabetes mellitus in pregnant women with polycystic ovary syndrome? Prospective cohort study","volume":"27","author":"Khattab","year":"2011","journal-title":"Gynecol Endocrinol"},{"key":"R28-12-20210226","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1210\/jcem.87.2.8207","article-title":"Effects of metformin on early pregnancy loss in the polycystic ovary syndrome","volume":"87","author":"Jakubowicz","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"R29-12-20210226","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).","volume":"19","year":"2004","journal-title":"Hum Reprod (Oxford England)"},{"key":"R30-12-20210226","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0950-351X(96)80099-1","article-title":"Ultrasound diagnosis of polycystic ovary syndrome","volume":"10","author":"Kyei-Mensah","year":"1996","journal-title":"Bailliere's Clin Endocrinol Metab"},{"key":"R31-12-20210226","first-page":"76","article-title":"Clinical, biochemical and ultrasonographic features of infertile women with polycystic ovarian syndrome","volume":"17","author":"Haq","year":"2007","journal-title":"J Coll Phys Surg Pakistan"},{"key":"R32-12-20210226","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1136\/bmj.332.7539.434","article-title":"Should obese women with polycystic ovary syndrome receive treatment for infertility?","volume":"332","author":"Balen","year":"2006","journal-title":"BMJ"},{"key":"R33-12-20210226","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ejogrb.2003.11.027","article-title":"Insulin resistance and metformin in polycystic ovary syndrome","volume":"115","author":"Ben-Haroush","year":"2004","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R34-12-20210226","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1056\/NEJMra041536","article-title":"Polycystic ovarian syndrome","volume":"352","author":"Ehrmann","year":"2005","journal-title":"N Engl J"},{"key":"R35-12-20210226","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/humrep\/16.2.226","article-title":"Obstetric outcome in women with polycystic ovarian syndrome","volume":"16","author":"Mikola","year":"2001","journal-title":"Hum Reprod (Oxford, England"},{"key":"R36-12-20210226","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1517\/14656566.3.11.1557","article-title":"The contentious nature of gestational diabetes: diet, insulin, glyburide and metformin","volume":"3","author":"Glueck","year":"2002","journal-title":"Expert Opin Pharmacother"},{"key":"R37-12-20210226","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1517\/14656566.3.8.1177","article-title":"Treatment of polycystic ovary syndrome with insulin-lowering agents","volume":"3","author":"Glueck","year":"2002","journal-title":"Expert Opin Pharmacother"},{"key":"R38-12-20210226","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ejogrb.2011.03.024","article-title":"The administration of metformin during pregnancy reduces polycystic ovary syndrome related gestational complications","volume":"157","author":"De Leo","year":"2011","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R39-12-20210226","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00431-008-0737-7","article-title":"Continuation of metformin in the first trimester of women with polycystic ovarian syndrome is not associated with increased perinatal morbidity","volume":"168","author":"Bolton","year":"2009","journal-title":"Eur J Pediatr"},{"key":"R40-12-20210226","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1093\/humrep\/17.11.2858","article-title":"Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin","volume":"17","author":"Glueck","year":"2002","journal-title":"Hum Reprod (Oxford, England"},{"key":"R41-12-20210226","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1093\/humrep\/deh109","article-title":"Metformin during pregnancy reduces insulin, insulin resistance, insulin secretion, weight, testosterone and development of gestational diabetes: prospective longitudinal assessment of women with polycystic ovary syndrome from preconception throughout pregnancy","volume":"19","author":"Glueck","year":"2004","journal-title":"Hum Reprod (Oxford, England"},{"key":"R42-12-20210226","first-page":"635","article-title":"Oral hypoglycaemics in the first trimester and fetal outcome","volume":"65","author":"Coetzee","year":"1984","journal-title":"South African Med J"},{"key":"R43-12-20210226","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1530\/EJE-09-0733","article-title":"Metformin: an old medication of new fashion: evolving new molecular mechanisms and clinical implications in polycystic ovary syndrome","volume":"162","author":"Diamanti-Kandarakis","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"R44-12-20210226","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.fertnstert.2006.02.098","article-title":"Pregnancy outcome after first-trimester exposure to metformin: a meta-analysis","volume":"86","author":"Gilbert","year":"2006","journal-title":"Fertil Steri"},{"key":"R45-12-20210226","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1213\/ane.0b013e3181a6ad5c","article-title":"Current therapeutic drugs for type 2 diabetes, still useful after 50 years?","volume":"108","author":"Hall","year":"2009","journal-title":"Anesth Analg"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000004526","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:31:03Z","timestamp":1620959463000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201609060-00012"}},"subtitle":["A meta-analysis"],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":45,"journal-issue":{"issue":"36","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000004526","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]}}}